CompuGroup Medical Operating Income Over Time
| 0MSD Stock | 16.22 10.30 38.84% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out CompuGroup Medical Performance and CompuGroup Medical Correlation. CompuGroup |
Cross Equities Operating Income Analysis
Compare CompuGroup Medical and related stocks such as Haydale Graphene Ind, Quantum Blockchain, and Chill Brands Group Operating Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HAYD | (656.8 K) | (642 K) | (1.1 M) | (2.2 M) | (3 M) | (4.1 M) | (5.3 M) | (6 M) | (5.5 M) | (5.3 M) | (4.5 M) | (5.9 M) | (6.2 M) | (6 M) | (6 M) | (5.4 M) | (5.6 M) |
| QBT | (600 K) | (14 M) | (316) | (1.5 M) | (1.9 M) | (654 K) | (894 K) | (324 K) | (3.4 M) | (1.4 M) | (1.1 M) | (5 M) | (4.5 M) | (4 M) | (3 M) | (3.4 M) | (3.6 M) |
| CHLL | (1.8 M) | (1.8 M) | (1.8 M) | (1.8 M) | (1.8 M) | (1.8 M) | (3.4 M) | (4 M) | (634.6 K) | (2.9 M) | (3.6 M) | (5.6 M) | (4 M) | (3.1 M) | (3.1 M) | (2.8 M) | (3 M) |
| VRS | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4.7 M) | (3.2 M) | (4.7 M) | (4.3 M) | (4.1 M) |
| MLVN | 435 K | 232 K | (3.5 M) | (1.7 M) | (1.1 M) | (1.4 M) | (1.5 M) | (692 K) | (673.2 K) | (2.4 M) | (1.3 M) | (1.3 M) | (872.8 K) | 126.6 K | 213.8 K | 192.4 K | 202 K |
CompuGroup Medical and related stocks such as Haydale Graphene Ind, Quantum Blockchain, and Chill Brands Group Operating Income description
Operating Income is the amount of profit realized from CompuGroup Medical operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of CompuGroup Medical AG is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| CompuGroup Medical AG | 0MSD |
| Classification | Drugs |
| Business Address | Maria Trost 21, |
| Exchange | London Exchange |
null 16.22
Additional Tools for CompuGroup Stock Analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.